Genetically augmenting tau levels does not modulate the onset or progression of Aβ pathology in transgenic mice
- 23 March 2007
- journal article
- Published by Wiley in Journal of Neurochemistry
- Vol. 102 (4), 1053-1063
- https://doi.org/10.1111/j.1471-4159.2007.04607.x
Abstract
The two hallmark pathologies of Alzheimer's disease (AD) are amyloid plaques, composed of the small amyloid-beta (Abeta) peptide, and neurofibrillary tangles, comprised aggregates of the microtubule binding protein, tau. The molecular linkage between these two lesions, however, remains unknown. Based on human and mouse studies, it is clear that the development of Abeta pathology can trigger tau pathology, either directly or indirectly. However, it remains to be established if the interaction between Abeta and tau is bidirectional and whether the modulation of tau will influence Abeta pathology. To address this question, we used the 3xTg-AD mouse model, which is characterized by the age-dependent buildup of both plaques and tangles. Here we show that genetically augmenting tau levels and hyperphosphorylation in the 3xTg-AD mice has no effect on the onset and progression of Abeta pathology. These data suggest that the link between Abeta and tau is predominantly if not exclusively unidirectional, which is consistent with the Abeta cascade hypothesis and may explain why tauopathy-only disorders are devoid of any Abeta pathology.Keywords
This publication has 29 references indexed in Scilit:
- Accelerated amyloid deposition, neurofibrillary degeneration and neuronal loss in double mutant APP/tau transgenic miceNeurobiology of Disease, 2005
- Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylationEuropean Journal of Neuroscience, 2005
- Up-Regulation of Inhibitors of Protein Phosphatase-2A in Alzheimer's DiseaseThe American Journal of Pathology, 2005
- Aβ Immunotherapy Leads to Clearance of Early, but Not Late, Hyperphosphorylated Tau Aggregates via the ProteasomeNeuron, 2004
- Clogging of axons by tau, inhibition of axonal traffic and starvation of synapsesNeurobiology of Aging, 2003
- Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles: Intracellular Aβ and Synaptic DysfunctionNeuron, 2003
- The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to TherapeuticsScience, 2002
- Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase BNature, 1995
- On the structure of microtubules, tau, and paired helical filamentsNeurobiology of Aging, 1995
- Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein productionNature, 1992